Zometa Concentrate:グローバル医薬品動向2014(販売量、特許、APIメーカー、治験動向など)

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIDR201483)
◆英語タイトル:Zometa Concentrate-Drug Insights,2014
◆発行会社/調査会社:DelveInsight
◆商品コード:DIDR201483
◆発行日:2014年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:25以上
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD1,000 ⇒換算¥111,000見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,000 ⇒換算¥222,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD3,000 ⇒換算¥333,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[Zometa Concentrate:グローバル医薬品動向2014(販売量、特許、APIメーカー、治験動向など)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

DelveInsight’s pharmaceuticals report, “Zometa Concentrate – Drug Insights, 2014” provides Zometa Concentrate marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical assessment of the drug, patent details, route of synthesis, competitive landscape, and analysis of sales performance during the forecast period (2011-2015). The report also includes SWOT analysis for the drug. This report is built using data and information sourced from DelveInsight proprietary databases, primary and secondary research using Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by DelveInsight team of industry experts.

Data Sources
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated drug.


• A review of the Zometa Concentrate based on information derived from company and industry-specific sources
• Coverage of the Marketed data of the Zometa Concentrate on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
• Coverage of the United States Drug Master File (US DMF), Active Substance Master File/EU DMF and API Manufactures in China & India for Schizophrenia drugs with location details
• Patent Expiry Timeline and Exclusivity Details
• Route of Synthesis of the API
• Global Forecasted Sales Figure from 2011-2015
• Qualitative and quantitative assessment of market space
• SWOT Analysis

• Evaluate the marketing status and exclusivity details of Zometa Concentrate to exploit opportunities for generic drug development opportunities.
• Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Zometa Concentrate.
• API intelligence over Zometa Concentrate and gaining primary intelligence over Active Ingredients manufacturers across the globe.
• Understanding the chemical route of synthesis of Zometa Concentrate.
• Uncovering opportunities in the rapidly growing the US market
• Stay ahead of competition by understanding the changing competitive landscape
• Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
• Make more informed business decisions from insightful and in-depth analysis of the drug’s performance
• Obtain sales forecast for currently marketed drug for 2011-2015

*** レポート目次(コンテンツ)***

• Drug Overview
• Global Sales Assessment
• Product Description
• Mechanism of Action
• Pharmacodynamic Properties
• Pharmacokinetic Properties
• Marketed Details for the United States
• Marketed Details for the Europe
• Patent Information
• Patent and Exclusivity Expiry Assessment United States (US)
• Patent Numbers and Expiry Details
• Patent Details
• Route of Synthesis
• Global API Manufacturers Assessment
• The United States Drug Master File (US DMF)
• The Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF)
• The Active Pharmaceutical Ingredient (API) Manufacturers in the ASIA Region
• The Active Pharmaceutical Ingredient (API) Manufacturers by the United States Drug Master (DMF) File Status
• The Active Pharmaceutical Ingredient (API) Manufacturers by Region
• The Active Pharmaceutical Ingredient (API) Manufacturers by Location/Countries
• Generic Players
• The Pipeline Coverage
• Clinical Trials Information
• Clinical Trials by Zone
• Company Profile
• Summary
• Company Financials
• SWOT Analysis
• References
• Appendix
• Methodology
• About DelveInsight
• Contact Us
• Disclaimer

• Zometa Concentrate, Market, Global Sales (in USD), 2014
• Zometa Concentrate, Description
• Zometa Concentrate, Marketed Details the United States (US)
• Zometa Concentrate, Marketed Details the Europe (EU)
• Zometa Concentrate, Patent/Exclusivity Expiry (Year), 2014
• Zometa Concentrate, Patent Number Specific Patent Expiry (Year), 2014
• Zometa Concentrate, Patent Details
• Zometa Concentrate, Route of Synthesis
• Zometa Concentrate, the United States Drug Master File (US DMF), 2014
• Zometa Concentrate, the Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF), 2014
• Zometa Concentrate, the API Manufacturers, China, 2014
• Zometa Concentrate, the API Manufacturers, India, 2014
• Zometa Concentrate, the API Manufacturers by the US DMF Status, 2014
• Zometa Concentrate, the API Manufacturers by Region, 2014
• Zometa Concentrate, the API Manufacturers by Location/Countries, 2014
• Zometa Concentrate, Generic Players, 2014
• Zometa Concentrate, Pipeline Drug Details, 2014
• Zometa Concentrate, Clinical Trials, 2014
• Zometa Concentrate, Clinical Trials by Zone, 2014
• Company Overview, 2014
• Zometa Concentrate, SWOT Analysis, 2014
• Phase III Pipeline Therapeutics, 2014

• Zometa Concentrate, Market, Global Sales (in million USD), 2014
• Zometa Concentrate, Global Sales % Change, 2014
• Zometa Concentrate, Patent/Exclusivity Expiry (Year), 2014
• Zometa Concentrate, Patent Number Specific Patent Expiry (Year), 2014
• Zometa Concentrate, Route of synthesis
• Zometa Concentrate, the API Manufacturers by the US DMF Status (%), 2014
• Zometa Concentrate, the API Manufacturers by Region, 2014
• Zometa Concentrate, the API Manufacturers by Location/Countries, 2014
• Zometa Concentrate, Generic Players, 2014
• Zometa Concentrate, Clinical Trials by Zone (%), 2014

*** レポートのキーワード ***

Oncology、Zometa Concentrate、医薬品、販売量、特許、医薬品有効成分(API)メーカー、治験動向 、製薬、企業

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 個人衛生用品市場の展望(~2017):ルーマニア(市場規模、流通・ブランドシェア、主要イベント、競争環境)
    Product Synopsis "The Future of the Personal Hygiene Market in Romania to 2017: Market Size, Distribution and Brand Share, Key Events and Competitive Landscape" is the result of Canadean’s extensive market and company research. This report presents detailed analysis on the Personal Hygiene consumpti …
  • Inland Homes PLC (INL):企業概要・分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Inland Homes PLC" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. World Market Intelligence …
  • パーマネントイエローGRの世界市場2015
    Permanent Yellow GR (CAS 5102-83-0) Market Research Report 2015 aims at providing comprehensive data on Permanent Yellow GR market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Permanent Yellow GR description, covers its application areas, manufacturin …
  • 世界のメチオカルブ市場2017
    Notes:Sales, means the sales volume of Methiocarb Revenue, means the sales value of Methiocarb This report studies sales (consumption) of Methiocarb in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue a …
  • エポキシ化大豆油の世界市場2015
    Global Epoxidized Soybean Oil Industry Report 2015 is a professional and in-depth study on the current state of the Epoxidized Soybean Oil industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Epoxidized …
  • チーズ系スナックの世界市場2018-2022
    116 Pages, November 2018 About this market The cheese-based snacks market has witnessed a myriad of innovations over the last few years and there has been constant launch of new products in the market. For instance, In July 2017, Hormel Foods launched a new snack, a meat-cheese-and-sweet item, under …
  • 世界の大口径シンチレーション計市場2016
    Notes:Production, means the output of Large Aperture Scintillometer Revenue, means the sales value of Large Aperture Scintillometer This report studies Large Aperture Scintillometer in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufact …
  • バングラデシュの温度計(液体温度計、その他)市場(~2020):市場規模、動向、予測
    The report Thermometer Market in Bangladesh to 2020 - Market Size, Development, and Forecasts offers the most up-to-date industry data on the actual market situation, and future outlook for thermometers in Bangladesh. The research includes historic data from 2009 to 2015 and forecasts until 2020 whi …
  • シンガポールの動物性脂肪市場
    The report presents analysis of animal fat market in Singapore. Scope Brief country profile includes general information and main economic indicators and specifies business environment in Singapore Animal Fat market is analyzed by different parameters including domestic production and consumption. F …
  • 回路遮断器・リレー・ヒューズの世界市場2016-2020
    About Circuit Breaker Fuse and Relay Circuit breakers are electrical switches that protect electric circuit from short-circuiting and overloading. These switches are designed to detect overloading and cut power supply automatically. Fuse prevents electricity overload by melting a wire inside the cir …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIDR201483 )"Zometa Concentrate:グローバル医薬品動向2014(販売量、特許、APIメーカー、治験動向など)" (英文:Zometa Concentrate-Drug Insights,2014)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。